Profile image
By marketresearchnest
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Gastric Cancer Therapeutics Companies Pipeline Review H1 2017

Thursday, May 18, 2017 4:49
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “Gastric Cancer – Pipeline Review, H1 2017” new report to its research database. The report spread across in multiple pages with table and figures in it.


Latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H1 2017, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy.

Browse full table of contents and data tables at

The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 1, 14, 70, 77, 7, 74, 12 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 7, 4, 8 and 1 molecules, respectively.

Gastric Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Gastric Cancer – Companies Involved in Therapeutics Development

3SBio Inc

AB Science SA

AbbVie Inc

AbGenomics International Inc

Abion Inc

Adaptimmune Therapeutics Plc

ADC Therapeutics Sarl

Aduro BioTech Inc

Advaxis Inc

Advenchen Laboratories LLC

Agenus Inc

Almac Discovery Ltd

Alteogen Inc

Ambrx Inc

amcure GmbH

Amgen Inc

ANP Technologies Inc

Antikor Biopharma Ltd


Array BioPharma Inc

Asana BioSciences LLC

Aslan Pharmaceuticals Pte Ltd

Astellas Pharma Inc

AstraZeneca Plc

Athenex Inc

Basilea Pharmaceutica Ltd

Bayer AG

BeiGene Ltd

Beijing Hanmi Pharmaceutical Co Ltd

Betta Pharmaceuticals Co Ltd

Bionovis SA

Boehringer Ingelheim GmbH

Boston Biomedical Inc

Bristol-Myers Squibb Company

Camel-IDS NV

Cancer Prevention Pharmaceuticals Inc

CBT Pharmaceuticals Inc

Celgene Corp

Celldex Therapeutics Inc

Cellectar Biosciences Inc

Celltrion Inc

Celon Pharma SA

Chipscreen Biosciences Ltd

Curaxys SL

Cytori Therapeutics Inc

Daiichi Sankyo Company Ltd

Debiopharm International SA

Deciphera Pharmaceuticals LLC

Dr. Reddy’s Laboratories Ltd

Eli Lilly and Company

EOS Biosciences Inc

Erytech Pharma SA

Esperance Pharmaceuticals Inc

Exelixis Inc

F-star Biotechnology Ltd

F. Hoffmann-La Roche Ltd

Five Prime Therapeutics Inc

Frost Biologic Inc

Galena Biopharma Inc

Genelux Corp

Genentech Inc

Gilead Sciences Inc

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

GlycoNex Inc

Glycotope GmbH

Green Cross Corp

Halozyme Therapeutics Inc

Hanmi Pharmaceuticals Co Ltd

Horizon Pharma Plc

Hutchison China MediTech Ltd

Ignyta Inc

Ildong Pharmaceutical Co Ltd

Immunomedics Inc

Incyte Corp

Inovio Pharmaceuticals Inc

Inspyr Therapeutics Inc

Insys Therapeutics Inc

Intezyne Technologies Inc

Ipsen SA

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Johnson & Johnson

KaloBios Pharmaceuticals Inc

And Many More


Order a Purchase Report Copy at


Featured News & Press Releases
Jul 27, 2016: Bavarian Nordic Announces Initiation of NIH Sponsored Phase 1 Trial of MVA-BN-based Gastric Cancer Vaccine
Jul 27, 2016: NIH launches early-stage Gastric Cancer vaccine trial
Apr 07, 2011: Xcellerex Announces Positive Results From Phase I Clinical Trial Of XRX-001


Scope of this Report

- The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Gastric Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Gastric Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Cancer (Oncology)


Request Sample Copy at


About Us:                  is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.


Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]


Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.